ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients. (Q51017212)
Jump to navigation
Jump to search
scientific article published on 2 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients. |
scientific article published on 2 July 2011 |
Statements
1 reference
ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients. (English)
1 reference
Michael Tachezy
1 reference
Hilke Zander
1 reference
Andreas H Marx
1 reference
Florian Gebauer
1 reference
Tamina Rawnaq
1 reference
Jussuf T Kaifi
1 reference
Guido Sauter
1 reference
Jakob R Izbicki
1 reference
Maximilian Bockhorn
1 reference
2 July 2011
1 reference
170
1 reference
226-232
1 reference
2
1 reference
Identifiers
1 reference